Total Funding
42
51
Total FundingSeries C raised
Growth Score
-3 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
47202
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Gregory Hebrank: Co-Founder, EVP- Armando Signore: Senior Research Investigator
About the Company
Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetic
testing. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families.
Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.
